New Tool Helps Doctors Choose Better Epilepsy Medications
This study looked at a new online tool called EPstat, which provides doctors with real-world data about how well different epilepsy medications work for patients.
This study looked at a new online tool called EPstat, which provides doctors with real-world data about how well different epilepsy medications work for patients.
Researchers studied how well patients with epilepsy and their caregivers understand Sudden Unexpected Death in Epilepsy (SUDEP), which is a serious risk associated with epilepsy.
This study looked at the risk factors for developing post-stroke epilepsy (PSE) in children who have had a stroke.
This study focused on adults with moyamoya disease (MMD), a condition that causes narrowing of blood vessels in the brain, leading to strokes.
This study focused on a new way to measure the effectiveness of epilepsy treatments, specifically looking at a drug called brivaracetam.
Researchers studied how the ketogenic diet (KD) affects the microbiota-gut-brain axis (MGBA) in people with drug-resistant epilepsy (DRE).
Researchers studied a patient with unusual movement problems linked to a change in the PRRT2 gene.
This study looked at how effective and safe four different medicationsβbrivaracetam, cenobamate, lacosamide, and perampanelβare for adults with drug-resistant focal epilepsy.
Researchers studied a technique called external trigeminal nerve stimulation (eTNS) to see how it might help with various neuropsychiatric disorders.